Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Other Working Capital Changes: 2020-2024

Historic Other Working Capital Changes for Cardiol Therapeutics (CRDL) over the last 5 years, with Dec 2024 value amounting to $156,987.

  • Cardiol Therapeutics' Other Working Capital Changes rose 127.07% to $1.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $3.1 million, marking a year-over-year change of. This contributed to the annual value of $156,987 for FY2024, which is 61.24% down from last year.
  • Latest data reveals that Cardiol Therapeutics reported Other Working Capital Changes of $156,987 as of FY2024, which was down 61.24% from $405,026 recorded in FY2023.
  • Cardiol Therapeutics' 5-year Other Working Capital Changes high stood at $1.0 million for FY2022, and its period low was -$1.7 million during FY2021.
  • Moreover, its 3-year median value for Other Working Capital Changes was $405,026 (2023), whereas its average is $532,508.
  • In the last 5 years, Cardiol Therapeutics' Other Working Capital Changes tumbled by 3,478.64% in 2021 and then soared by 160.43% in 2022.
  • Cardiol Therapeutics' Other Working Capital Changes (MRY) stood at -$47,881 in 2020, then crashed by 3,478.64% to -$1.7 million in 2021, then skyrocketed by 160.43% to $1.0 million in 2022, then plummeted by 60.89% to $405,026 in 2023, then plummeted by 61.24% to $156,987 in 2024.
  • Its last three reported values are $156,987 in FY2024, $405,026 for FY2023, and $1.0 million during FY2022.